Plant-Derived Flavonoids as AMPK Activators: Unveiling Their Potential in Type 2 Diabetes Management through Mechanistic Insights, Docking Studies, and Pharmacokinetics
Source abstract
Abstract
Type 2 diabetes mellitus (T2DM) remains a significant global health issue, marked by insulin resistance and disrupted glucose metabolism. AMP-activated protein kinase (AMPK) serves as a key regulator of cellular energy balance, playing a crucial role in enhancing insulin sensitivity, promoting glucose uptake, and reducing glucose production in the liver. Recently, there has been growing interest in plant-derived flavonoids as natural activators of AMPK, offering a promising complementary approach to conventional diabetes treatments. This review delves into ten flavonoids identified as AMPK activators, including baicalein, dihydromyricetin, bavachin, 7-O-MA, derrone, and alpinumisoflavone. Their activation mechanisms are explored, which include both direct binding to the AMPK complex and indirect pathways involving upstream signaling. Through molecular docking studies, the binding affinities and interaction profiles of these flavonoids with AMPK are assessed, revealing varying levels of activation potential. Notably, baicalein and dihydromyricetin showed strong binding to the α1 subunit of AMPK, indicating high potential for robust activation. Additionally, this review provides a thorough analysis of the pharmacokinetic properties and drug-likeness of these flavonoids using the SwissADME tool, focusing on aspects such as ADME (Absorption, Distribution, Metabolism, and Excretion). While the overall profiles of these compounds are promising, issues like solubility and possible drug–drug interactions are areas that need further refinement. In summary, plant-derived flavonoids emerge as a promising avenue for developing new natural therapies for T2DM. Moving forward, research should aim at optimizing these compounds for clinical application, elucidating their specific mechanisms of AMPK activation, and confirming their efficacy in T2DM treatment. This review highlights the potential of flavonoids as safer and more holistic alternatives or adjuncts to current diabetes therapies.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Metabolism, Diabetes, and Cancer · Natural Antidiabetic Agents Studies · Plant Gene Expression Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biology Education, Daegu University, 201, Daegudae-ro, Gyeongsan-si 38453, Gyeongsangbuk-do, Republic of Korea
References (89)
Show source-provided references
1. Artasensi, A., Pedretti, A., Vistoli, G., and Fumagalli, L. (2020). Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs. Molecules, 25.10.3390/molecules25081987 ↗
2. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications10.1038/nrendo.2017.151 ↗
3. A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data10.1016/j.jdiacomp.2017.08.005 ↗
4. Dahlén, A.D., Dashi, G., Maslov, I., Attwood, M.M., Jonsson, J., Trukhan, V., and Schiöth, H.B. (2021). Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales. Front. Pharmacol., 12.10.3389/fphar.2021.807548 ↗
5. Szymczak-Pajor, I., Wenclewska, S., and Śliwińska, A. (2022). Metabolic Action of Metformin. Pharmaceuticals, 15.10.3390/ph15070810 ↗
6. Goel, S., Singh, R., Singh, V., Singh, H., Kumari, P., Chopra, H., Sharma, R., Nepovimova, E., Valis, M., and Kuca, K. (2022). Metformin: Activation of 5′ AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action. Front. Genet., 13.10.3389/fgene.2022.1022739 ↗
7. AMP-activated protein kinase inhibits NF-κB signaling and inflammation: Impact on healthspan and lifespan10.1007/s00109-011-0748-0 ↗
8. Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-κB pathway10.1016/j.metabol.2018.03.004 ↗
9. Covalent activation of heart AMP-activated protein kinase in response to physiological concentrations of long-chain fatty acids10.1111/j.1432-1033.2004.04151.x ↗
10. Dietary polyunsaturated fatty acids enhance hepatic AMP-activated protein kinase activity in rats10.1016/j.bbrc.2004.11.114 ↗
11. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus10.1172/JCI117600 ↗
12. Yi, X., Dong, M., Guo, N., Tian, J., Lei, P., Wang, S., Yang, Y., and Shi, Y. (2023). Flavonoids improve type 2 diabetes mellitus and its complications: A review. Front. Nutr., 10.10.3389/fnut.2023.1192131 ↗
13. Flavonoids and type 2 diabetes: Evidence of efficacy in clinical and animal studies and delivery strategies to enhance their therapeutic efficacy10.1016/j.phrs.2020.104629 ↗
14. Antidiabetic properties of dietary flavonoids: A cellular mechanism review10.1186/s12986-015-0057-7 ↗
15. Flavonoids as natural phenolic compounds and their role in therapeutics: An overview10.1186/s43094-020-00161-8 ↗
16. Activation of AMPK by Medicinal Plants and Natural Products: Its Role in Type 2 Diabetes Mellitus10.2174/1389557519666181128120726 ↗
17. Metformin; a review of its history and future: From lilac to longevity10.1111/pedi.12473 ↗
18. Hypoglycemic activity of a novel anthocyanin-rich formulation from lowbush blueberry, Vaccinium angustifolium Aiton10.1016/j.phymed.2009.02.018 ↗
19. Recent advances in understanding the anti-diabetic actions of dietary flavonoids10.1016/j.jnutbio.2013.06.003 ↗
20. Quercetin modulates AMPK/SIRT1/NF-κB signaling to inhibit inflammatory/oxidative stress responses in diabetic high fat diet-induced atherosclerosis in the rat carotid artery10.3892/etm.2020.9410 ↗
21. Zhang, N., Zhang, W., Guo, X., Liu, J., Li, S., Zhang, H., and Fan, B. (2022). Genistein protects against hyperglycemia and fatty liver disease in diet-induced prediabetes mice via activating hepatic insulin signaling pathway. Front. Nutr., 9.10.3389/fnut.2022.1072044 ↗
22. Liu, C., Ma, J., Sun, J., Cheng, C., Feng, Z., Jiang, H., and Yang, W. (2017). Flavonoid-Rich Extract of Paulownia fortunei Flowers Attenuates Diet-Induced Hyperlipidemia, Hepatic Steatosis and Insulin Resistance in Obesity Mice by AMPK Pathway. Nutrients, 9.10.3390/nu9090959 ↗
23. AMPK: Guardian of metabolism and mitochondrial homeostasis10.1038/nrm.2017.95 ↗
24. New insights into activation and function of the AMPK10.1038/s41580-022-00547-x ↗
25. Yan, Y., Zhou, X.E., Xu, H.E., and Melcher, K. (2018). Structure and Physiological Regulation of AMPK. Int. J. Mol. Sci., 19.10.3390/ijms19113534 ↗
26. Predominant alpha2/beta2/gamma3 AMPK activation during exercise in human skeletal muscle10.1113/jphysiol.2006.120972 ↗
27. AMPK activators: Mechanisms of action and physiological activities10.1038/emm.2016.16 ↗
28. Structure of mammalian AMPK and its regulation by ADP10.1038/nature09932 ↗
29. AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation10.1016/j.cmet.2013.08.019 ↗
30. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells10.1016/j.cmet.2005.06.005 ↗
31. LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective10.1155/2019/8730816 ↗
32. 5′-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms10.1074/jbc.270.45.27186 ↗
33. 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC10.1016/0014-5793(95)01368-7 ↗
34. AMPK is a direct adenylate charge-regulated protein kinase10.1126/science.1200094 ↗
35. Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: Impact on glucose-stimulated insulin secretion10.1152/ajpendo.00532.2003 ↗
36. Chronic palmitate exposure inhibits AMPKalpha and decreases glucose-stimulated insulin secretion from beta-cells: Modulation by fenofibrate10.1111/j.1745-7254.2008.00717.x ↗
37. The dual control of insulin secretion by glucose involves triggering and amplifying pathways in β-cells10.1016/S0168-8227(11)70010-9 ↗
38. Metabolic signaling in fuel-induced insulin secretion10.1016/j.cmet.2013.05.018 ↗
39. Insulinotropic action of AICA riboside. I. Insulin release by isolated islets and the perfused pancreas
40. Insulinotropic action of AICA riboside. II. Secretory, metabolic and cationic aspects
41. Pepin, É., Al-Mass, A., Attané, C., Zhang, K., Lamontagne, J., Lussier, R., Madiraju, S.R., Joly, E., Ruderman, N.B., and Sladek, R. (2016). Pancreatic β-Cell Dysfunction in Diet-Induced Obese Mice: Roles of AMP-Kinase, Protein Kinase Cε, Mitochondrial and Cholesterol Metabolism, and Alterations in Gene Expression. PLoS ONE, 11.10.1371/journal.pone.0153017 ↗
42. Palmitate activates AMP-activated protein kinase and regulates insulin secretion from beta cells10.1016/j.bbrc.2006.11.032 ↗
43. The Paradoxical Effects of AMPK on Insulin Gene Expression and Glucose-Induced Insulin Secretion10.1002/jcb.25271 ↗
44. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: Role in beta-cell adaptation and failure in the etiology of diabetes10.2337/diabetes.51.2007.S405 ↗
45. Herman, R., Kravos, N.A., Jensterle, M., Janež, A., and Dolžan, V. (2022). Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport. Int. J. Mol. Sci., 23.10.3390/ijms23031264 ↗
46. Rosemary extract activates AMPK, inhibits mTOR and attenuates the high glucose and high insulin-induced muscle cell insulin resistance10.1139/apnm-2020-0592 ↗
47. Expression and purification of asprosin in Pichia pastoris and investigation of its increase glucose uptake activity in skeletal muscle through activation of AMPK10.1016/j.enzmictec.2020.109737 ↗
48. Promalabaricone B from Myristica fatua Houtt. seeds demonstrate antidiabetic potential by modulating glucose uptake via the upregulation of AMPK in L6 myotubes10.1080/14786419.2019.1607852 ↗
49. Prenylflavonoids from fruit of Macaranga tanarius promote glucose uptake via AMPK activation in L6 myotubes10.1007/s11418-021-01517-x ↗
50. Lee, H.A., Cho, J.H., Afinanisa, Q., An, G.H., Han, J.G., Kang, H.J., Choi, S.H., and Seong, H.A. (2020). Ganoderma lucidum Extract Reduces Insulin Resistance by Enhancing AMPK Activation in High-Fat Diet-Induced Obese Mice. Nutrients, 12.10.3390/nu12113338 ↗
51. Polyphenols: Food sources and bioavailability10.1093/ajcn/79.5.727 ↗
52. Overview of dietary flavonoids: Nomenclature, occurrence and intake10.1093/jn/133.10.3248S ↗
53. Flavonols, flavones, flavanones, and human health: Epidemiological evidence10.1089/jmf.2005.8.281 ↗
54. Polyphenols and disease risk in epidemiologic studies10.1093/ajcn/81.1.317S ↗
55. Impact of dietary polyphenols on carbohydrate metabolism10.3390/ijms11041365 ↗
56. Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1α-Sirt3 signaling pathway10.1007/s12020-015-0599-5 ↗
57. Lee, H., Li, H., Noh, M., and Ryu, J.H. (2016). Bavachin from Psoralea corylifolia Improves Insulin-Dependent Glucose Uptake through Insulin Signaling and AMPK Activation in 3T3-L1 Adipocytes. Int. J. Mol. Sci., 17.10.3390/ijms17040527 ↗
58. 7-O-methylaromadendrin stimulates glucose uptake and improves insulin resistance in vitro10.1248/bpb.33.1494 ↗
59. Ma, Y., Yang, F., Wang, Y., Du, Z., Liu, D., Guo, H., Shen, J., and Peng, H. (2012). CaMKKβ is involved in AMP-activated protein kinase activation by baicalin in LKB1 deficient cell lines. PLoS ONE, 7.10.1371/journal.pone.0047900 ↗
60. Differential regulation of baicalin and scutellarin on AMPK and Akt in promoting adipose cell glucose disposal10.1016/j.bbadis.2016.11.024 ↗
61. Baicalein, a natural product, selectively activating AMPKα(2) and ameliorates metabolic disorder in diet-induced mice10.1016/j.mce.2012.06.002 ↗
62. Dhanya, R., Arya, A.D., Nisha, P., and Jayamurthy, P. (2017). Quercetin, a Lead Compound against Type 2 Diabetes Ameliorates Glucose Uptake via AMPK Pathway in Skeletal Muscle Cell Line. Front. Pharmacol., 8.10.3389/fphar.2017.00336 ↗
63. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase10.1016/j.bbrc.2005.09.195 ↗
64. Genistein-derivatives from Tetracera scandens stimulate glucose-uptake in L6 myotubes10.1248/bpb.32.504 ↗
65. Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice10.1007/s00394-012-0466-6 ↗
66. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain10.1042/bj3480607 ↗
67. The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways10.1074/jbc.M202489200 ↗
68. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?10.1111/j.1432-1033.1995.tb20498.x ↗
69. Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase10.1016/0014-5793(94)01006-4 ↗
70. Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes10.1016/j.chembiol.2008.10.005 ↗
71. A769662, a novel activator of AMP-activated protein kinase, inhibits non-proteolytic components of the 26S proteasome by an AMPK-independent mechanism10.1016/j.febslet.2008.06.044 ↗
72. The ancient drug salicylate directly activates AMP-activated protein kinase10.1126/science.1215327 ↗
73. Mechanism of action of compound-13: An α1-selective small molecule activator of AMPK10.1016/j.chembiol.2014.05.014 ↗
74. Structural basis of AMPK regulation by small molecule activators10.1038/ncomms4017 ↗
75. Genistein promotes insulin action through adenosine monophosphate-activated protein kinase activation and p70 ribosomal protein S6 kinase 1 inhibition in the skeletal muscle of mice fed a high energy diet10.1016/j.nutres.2012.06.002 ↗
76. Akinfenwa, A.O., Abdul, N.S., Marnewick, J.L., and Hussein, A.A. (2021). Protective Effects of Linearthin and Other Chalcone Derivatives from Aspalathus linearis (Rooibos) against UVB Induced Oxidative Stress and Toxicity in Human Skin Cells. Plants, 10.10.3390/plants10091936 ↗
77. Flavonoid bioavailability and attempts for bioavailability enhancement10.3390/nu5093367 ↗
78. The effects of selected flavonoids on cytochromes P450 in rat liver and small intestine
79. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview10.1016/j.ijpharm.2019.118642 ↗
80. In silico ADME/T modelling for rational drug design10.1017/S0033583515000190 ↗
81. ADME pharmacogenetics: Current practices and future outlook10.1517/17425250902902322 ↗
82. Daina, A., Michielin, O., and Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep., 7.10.1038/srep42717 ↗
83. ADME Prediction, Structure-activity Relationship of Boswellic Acid Scaffold for the Aspect of Anticancer & Anti-inflammatory Potency10.2174/1871520623666230417080437 ↗
84. Al-Ishaq, R.K., Abotaleb, M., Kubatka, P., Kajo, K., and Büsselberg, D. (2019). Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels. Biomolecules, 9.10.3390/biom9090430 ↗
85. Flavonoids, bioactive components of propolis, exhibit cytotoxic activity and induce cell cycle arrest and apoptosis in human breast cancer cells MDA-MB-231 and MCF-7—A comparative study10.14715/cmb/2018.64.8.1 ↗
86. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs10.1021/bi035613d ↗
87. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate10.1016/j.fct.2014.12.009 ↗
88. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice10.1016/j.fct.2009.10.030 ↗
89. Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats10.3945/jn.111.148247 ↗